Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas

[1]  P. Tran,et al.  The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma , 2015, American journal of clinical oncology.

[2]  Yoshiyuki Suzuki,et al.  Topics in chemotherapy, molecular-targeted therapy, and immunotherapy for newly-diagnosed glioblastoma multiforme. , 2015, Anticancer research.

[3]  S. Grossman,et al.  Association between severe treatment‐related lymphopenia and progression‐free survival in patients with newly diagnosed squamous cell head and neck cancer , 2014, Head & neck.

[4]  D. Gomez,et al.  Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes. , 2014, International journal of radiation oncology, biology, physics.

[5]  D. Gladstone,et al.  Infusion of cryopreserved autologous lymphocytes using a standard peripheral i.v. catheter , 2014, Bone Marrow Transplantation.

[6]  C. Drake,et al.  Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide , 2014, Oncoimmunology.

[7]  M. Brock,et al.  Treatment-related Lymphopenia in Patients With Stage III Non-Small-Cell Lung Cancer , 2013, Cancer investigation.

[8]  Lawrence Kleinberg,et al.  The Etiology of Treatment-related Lymphopenia in Patients with Malignant Gliomas: Modeling Radiation Dose to Circulating Lymphocytes Explains Clinical Observations and Suggests Methods of Modifying the Impact of Radiation on Immune Cells , 2013, Cancer investigation.

[9]  S. Grossman,et al.  The Association Between Treatment-Related Lymphopenia and Survival in Newly Diagnosed Patients with Resected Adenocarcinoma of the Pancreas , 2012, Cancer investigation.

[10]  C. Mackall,et al.  IL-7 in human health and disease. , 2012, Seminars in immunology.

[11]  George Coukos,et al.  Cancer immunotherapy comes of age , 2011, Nature.

[12]  S. Piantadosi,et al.  Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide , 2011, Clinical Cancer Research.

[13]  M. Tan,et al.  Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells , 2009, Clinical Cancer Research.

[14]  J. Blay,et al.  Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. , 2009, Cancer research.

[15]  A. Grulich.  Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation , 2009, Current opinion in HIV and AIDS.

[16]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[17]  O. Kirk,et al.  HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies , 2008, AIDS.

[18]  D. Venzon,et al.  Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets , 2008, The Journal of experimental medicine.

[19]  W. Blackwelder,et al.  Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer , 2005, Nature Medicine.

[20]  S. Grossman,et al.  Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection. , 2005, International journal of radiation oncology, biology, physics.

[21]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[22]  K. Sepkowitz,et al.  Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  C Norman Coleman,et al.  Effects of radiation on normal tissue: consequences and mechanisms. , 2003, The Lancet. Oncology.

[24]  S. Hodge,et al.  Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[25]  S. Rodenhuis,et al.  Reinfusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Barretina,et al.  Interleukin-7 in Plasma Correlates with CD4 T-Cell Depletion and May Be Associated with Emergence of Syncytium-Inducing Variants in Human Immunodeficiency Virus Type 1-Positive Individuals , 2001, Journal of Virology.

[27]  M. Lederman,et al.  A potential role for interleukin-7 in T-cell homeostasis. , 2001, Blood.

[28]  J. Liesveld,et al.  TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors. , 1997, Journal of immunology.

[29]  U. Galili,et al.  The effect of radiation therapy on lymphocyte subpopulations in cancer patients , 1976, Cancer.

[30]  K. Meyer.  Radiation-induced lymphocyte-immune deficiency. A factor in the increased visceral metastases and decreased hormonal responsiveness of breast cancer. , 1970, Archives of surgery.